138 related articles for article (PubMed ID: 10575734)
1. Synthesis and X-ray crystal structure of the calcium channel antagonist: dimethyl 1,4-dihydro-2,6-dimethyl-4-[4'-(4H-4-oxo-1-benzopyran-2-yl)phenyl]- 3,5-pyridine dicarboxylate.
Tunçbilek M; Ozbey S; Kendi E; Yildirim E; Erol K; Ertan R
Farmaco; 1999 Oct; 54(10):660-5. PubMed ID: 10575734
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of 1,4-dihydropyridine-5-phosphonates and their calcium-antagonistic and antihypertensive activities: novel calcium-antagonist 2-[benzyl(phenyl)amino]ethyl 5-(5,5-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dim ethyl-4-(3-nitrophenyl)-3-pyridinecarboxylate hydrochloride ethanol (NZ-105) and its crystal structure.
Sakoda R; Kamikawaji Y; Seto K
Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2362-9. PubMed ID: 1446356
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and crystal structure of optically active 2-[benzyl(phenyl)amino]ethyl 5-(5,5-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dim ethyl-4-(3-nitrophenyl)-3-pyridinecarboxylate (NZ-105).
Sakoda R; Matsumoto H; Seto K
Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2377-81. PubMed ID: 1446358
[TBL] [Abstract][Full Text] [Related]
4. Cardioactivity and solid-state structure of two 4-isoxazolyldihydropyridines related to the 4-aryldihydropyridine calcium-channel blockers.
McKenna JI; Schlicksupp L; Natale NR; Willett RD; Maryanoff BE; Flaim SF
J Med Chem; 1988 Feb; 31(2):473-6. PubMed ID: 3339618
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and smooth muscle calcium channel effects of dialkyl 1,4-dihydro-2,6-dimethyl-4-aryl-3,5-pyridinedicarboxylates containing a nitrone moiety in the 4-aryl substituent.
Anana RD; Ng H; Howlett SE; Knaus EE
Arch Pharm (Weinheim); 1997 Mar; 330(3):53-8. PubMed ID: 9167447
[TBL] [Abstract][Full Text] [Related]
6. The new generation dihydropyridine type calcium blockers, bearing 4-phenyl oxypropanolamine, display alpha-/beta-adrenoceptor antagonist and long-acting antihypertensive activities.
Liang JC; Yeh JL; Wang CS; Liou SF; Tsai CH; Chen IJ
Bioorg Med Chem; 2002 Mar; 10(3):719-30. PubMed ID: 11814861
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of some 4-[3' or 4'-(4H- 4-oxo-1-benzopyran-2-yl)phenyl]-1,4-dihydropyridine derivatives as potential calcium channel antagonists.
Tunçbilek M; Ertan R
Pharmazie; 1999 Apr; 54(4):255-9. PubMed ID: 10234737
[TBL] [Abstract][Full Text] [Related]
8. 3-Methyl 5-isopropyl 2-methoxyiminomethyl-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate.
Vrábel V; Lehotay J; Oktavec D; Marchalín S
Acta Crystallogr C; 2001 Sep; 57(Pt 9):1073-4. PubMed ID: 11588375
[TBL] [Abstract][Full Text] [Related]
9. Microwave-assisted synthesis and spasmolytic activity of 4-indolylhexahydroquinoline derivatives.
El-Khouly A; Gündüz MG; Cengelli C; Simşek R; Erol K; Safak C; Yıldırım SO; Butcher RJ
Drug Res (Stuttg); 2013 Nov; 63(11):579-85. PubMed ID: 23804251
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, spectroscopic, DFT, and molecular docking studies on 1,4-dihydropyridine derivative compounds: a combined experimental and theoretical study.
Karthick R; Velraj G; Pachamuthu MP; Karthikeyan S
J Mol Model; 2021 Dec; 28(1):5. PubMed ID: 34889990
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and calcium channel-modulating effects of alkyl (or cycloalkyl) 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridyl-5-pyridinecarboxylate racemates and enantiomers.
Ramesh M; Matowe WC; Akula MR; Vo D; Dagnino L; Li-Kwong-Ken MC; Wolowyk MW; Knaus EE
J Med Chem; 1998 Feb; 41(4):509-14. PubMed ID: 9484501
[TBL] [Abstract][Full Text] [Related]
12. Calcium entry blockers and activators: conformational and structural determinants of dihydropyrimidine calcium channel modulators.
Rovnyak GC; Kimball SD; Beyer B; Cucinotta G; DiMarco JD; Gougoutas J; Hedberg A; Malley M; McCarthy JP; Zhang R
J Med Chem; 1995 Jan; 38(1):119-29. PubMed ID: 7837222
[TBL] [Abstract][Full Text] [Related]
13. Comparative QSAR studies of two series of 1,4-dihydropyridines as slow calcium channel blockers.
Wikel JH; Bemis KG; Kurz K; Denney ML; Main BW; Moore RA; Smith T; Shingleton L; Holland DR
Drug Des Discov; 1994 Jan; 11(1):1-14. PubMed ID: 8068815
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and calcium channel antagonist activity of dialkyl 1,4-dihydro-2,6-dimethyl-4-[4-(1-methoxycarbonyl-1,4-dihydropyridyl)]-3 ,5- pyridinedicarboxylates.
Ramesh M; Matowe WC; Wolowyk MW; Knaus EE
Arch Pharm (Weinheim); 1999 Nov; 332(11):385-8. PubMed ID: 10605379
[TBL] [Abstract][Full Text] [Related]
15. Two 1,4-dihydropyridine derivatives with potential calcium-channel antagonist activity.
Linden A; Safak C; Simşek R; Gündüz MG
Acta Crystallogr C; 2011 Feb; 67(Pt 2):o80-4. PubMed ID: 21285508
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, structure, and pharmacological evaluation of the stereoisomers of furnidipine.
Alajarin R; Vaquero JJ; Alvarez-Builla J; Pastor M; Sunkel C; Fau de Casa-Juana M; Priego J; Statkow PR; Sanz-Aparicio J; Fonseca I
J Med Chem; 1995 Jul; 38(15):2830-41. PubMed ID: 7636844
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, study of 3D structures, and pharmacological activities of lipophilic nitroimidazolyl-1,4-dihydropyridines as calcium channel antagonist.
Miri R; Javidnia K; Sarkarzadeh H; Hemmateenejad B
Bioorg Med Chem; 2006 Jul; 14(14):4842-9. PubMed ID: 16603367
[TBL] [Abstract][Full Text] [Related]
18. Receptor model for the molecular basis of tissue selectivity of 1, 4-dihydropyridine calcium channel drugs.
Langs DA; Strong PD; Triggle DJ
J Comput Aided Mol Des; 1990 Sep; 4(3):215-30. PubMed ID: 2177783
[TBL] [Abstract][Full Text] [Related]
19. 1,4-Dihydropyridine derivatives as calcium channel modulators: the role of 3-methoxy-flavone moiety.
Budriesi R; Bisi A; Ioan P; Rampa A; Gobbi S; Belluti F; Piazzi L; Valenti P; Chiarini A
Bioorg Med Chem; 2005 May; 13(10):3423-30. PubMed ID: 15848754
[TBL] [Abstract][Full Text] [Related]
20. [Synthesis of 2,6-dimethyl-4-disubstituted phenyl-1,4-dihydropyridine-3,5-dicarboxylates as antimyocardial ischemic agents].
Yan ZM; Dong YM
Yao Xue Xue Bao; 1991; 26(9):661-6. PubMed ID: 1821085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]